• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.10% Nasdaq Down 0.20%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    11.78 Down 0.34(2.81%) 11:57AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:12.12
    Open:12.14
    Bid:11.85 x 1300
    Ask:11.86 x 4200
    1y Target Est:14.64
    Beta:0.76
    Next Earnings Date:10-Aug-15NVAX Earnings announcement
    Day's Range:11.70 - 13.00
    52wk Range:3.92 - 13.12
    Volume:2,028,624
    Avg Vol (3m):3,503,690
    Market Cap:3.16B
    P/E (ttm):N/A
    EPS (ttm):-0.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVAXDown 2.81%3.16B
    MRKDown 0.46%166.07B
    NVSDown 0.47%250.86B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):98.18
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.41
    Quarterly EPS Est (Jun-15) :-0.09
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback